The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma

Lisa Rooper, Rajni Sharma, Christopher Gocke, Deborah A Belchis

Research output: Contribution to journalReview article

Abstract

Although molecular testing can definitively distinguish Ewing sarcoma (EWS) from synovial sarcoma (SS) it is frequently desirable to provide a confident preliminary diagnosis before such analysis can be completed. Recently, the nuclear markers NKX2.2 and TLE1 have been shown to have good sensitivity but imperfect specificity, respectively, for EWS and SS. However, the performance of these markers has not been extensively evaluated within this specific differential diagnosis. This study performed NKX2.2, TLE1, and CD99 immunohistochemistry in a group of EWS and SSs confirmed by reverse transcription-polymerase chain reaction to evaluate the utility of these novel markers in this context. NKX2.2 staining was overall 75% sensitive and 91.7% specific for EWS and was never seen in SS. Although the specificity of TLE1 staining was impacted by antibody used, it was at best only 75% specific for SS. However, a lack of reactivity had a 100% negative predictive value against a SS diagnosis. Overall, immunohistochemistry for NKX2.2 and TLE1 can provide a useful first step in helping to distinguish EWS and SS.

Original languageEnglish (US)
Pages (from-to)174-179
Number of pages6
JournalApplied Immunohistochemistry and Molecular Morphology
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Synovial Sarcoma
Ewing's Sarcoma
Immunohistochemistry
Staining and Labeling
Reverse Transcription
Differential Diagnosis
Sensitivity and Specificity
Polymerase Chain Reaction
Antibodies

Keywords

  • Ewing sarcoma
  • immunohistochemistry
  • molecular testing
  • synovial sarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Medical Laboratory Technology

Cite this

The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma. / Rooper, Lisa; Sharma, Rajni; Gocke, Christopher; Belchis, Deborah A.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 27, No. 3, 01.03.2019, p. 174-179.

Research output: Contribution to journalReview article

@article{c1b347d2f3e04fb99da389a3d92c2b7e,
title = "The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma",
abstract = "Although molecular testing can definitively distinguish Ewing sarcoma (EWS) from synovial sarcoma (SS) it is frequently desirable to provide a confident preliminary diagnosis before such analysis can be completed. Recently, the nuclear markers NKX2.2 and TLE1 have been shown to have good sensitivity but imperfect specificity, respectively, for EWS and SS. However, the performance of these markers has not been extensively evaluated within this specific differential diagnosis. This study performed NKX2.2, TLE1, and CD99 immunohistochemistry in a group of EWS and SSs confirmed by reverse transcription-polymerase chain reaction to evaluate the utility of these novel markers in this context. NKX2.2 staining was overall 75{\%} sensitive and 91.7{\%} specific for EWS and was never seen in SS. Although the specificity of TLE1 staining was impacted by antibody used, it was at best only 75{\%} specific for SS. However, a lack of reactivity had a 100{\%} negative predictive value against a SS diagnosis. Overall, immunohistochemistry for NKX2.2 and TLE1 can provide a useful first step in helping to distinguish EWS and SS.",
keywords = "Ewing sarcoma, immunohistochemistry, molecular testing, synovial sarcoma",
author = "Lisa Rooper and Rajni Sharma and Christopher Gocke and Belchis, {Deborah A}",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/PAI.0000000000000573",
language = "English (US)",
volume = "27",
pages = "174--179",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma

AU - Rooper, Lisa

AU - Sharma, Rajni

AU - Gocke, Christopher

AU - Belchis, Deborah A

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Although molecular testing can definitively distinguish Ewing sarcoma (EWS) from synovial sarcoma (SS) it is frequently desirable to provide a confident preliminary diagnosis before such analysis can be completed. Recently, the nuclear markers NKX2.2 and TLE1 have been shown to have good sensitivity but imperfect specificity, respectively, for EWS and SS. However, the performance of these markers has not been extensively evaluated within this specific differential diagnosis. This study performed NKX2.2, TLE1, and CD99 immunohistochemistry in a group of EWS and SSs confirmed by reverse transcription-polymerase chain reaction to evaluate the utility of these novel markers in this context. NKX2.2 staining was overall 75% sensitive and 91.7% specific for EWS and was never seen in SS. Although the specificity of TLE1 staining was impacted by antibody used, it was at best only 75% specific for SS. However, a lack of reactivity had a 100% negative predictive value against a SS diagnosis. Overall, immunohistochemistry for NKX2.2 and TLE1 can provide a useful first step in helping to distinguish EWS and SS.

AB - Although molecular testing can definitively distinguish Ewing sarcoma (EWS) from synovial sarcoma (SS) it is frequently desirable to provide a confident preliminary diagnosis before such analysis can be completed. Recently, the nuclear markers NKX2.2 and TLE1 have been shown to have good sensitivity but imperfect specificity, respectively, for EWS and SS. However, the performance of these markers has not been extensively evaluated within this specific differential diagnosis. This study performed NKX2.2, TLE1, and CD99 immunohistochemistry in a group of EWS and SSs confirmed by reverse transcription-polymerase chain reaction to evaluate the utility of these novel markers in this context. NKX2.2 staining was overall 75% sensitive and 91.7% specific for EWS and was never seen in SS. Although the specificity of TLE1 staining was impacted by antibody used, it was at best only 75% specific for SS. However, a lack of reactivity had a 100% negative predictive value against a SS diagnosis. Overall, immunohistochemistry for NKX2.2 and TLE1 can provide a useful first step in helping to distinguish EWS and SS.

KW - Ewing sarcoma

KW - immunohistochemistry

KW - molecular testing

KW - synovial sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85055665905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055665905&partnerID=8YFLogxK

U2 - 10.1097/PAI.0000000000000573

DO - 10.1097/PAI.0000000000000573

M3 - Review article

C2 - 28800015

AN - SCOPUS:85055665905

VL - 27

SP - 174

EP - 179

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 3

ER -